Back to Qube Research & Technologies Ltd Qube Research & Technologies Ltd

CUCURE
Showing 6 of 20 quarters

Position history for Qube Research & Technologies LtdQube Research & Technologies Ltd's holdings in DIREXION DAILY HEALTHCARE BULL 3X ETF

Qube Research & Technologies Ltd holds 1,212 shares of CURE (DIREXION DAILY HEALTHCARE BULL 3X ETF), worth $135,950 as of 2026-Q2. This is a new position. CURE represents 0.0% of Qube Research & Technologies Ltd's portfolio.

Current Value

$135,950

Current Shares

1,212

Total Value Change

+$26,210

Total Shares Change

+388

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
New
1,212
-
$135,9500.0%$112.17
31
2025-Q3
Exited
0
-100.0%
$00.0%$77.63
0
2025-Q2
New
1,998
-
$157,4820.0%$76.91
31
2025-Q1
Exited
0
-100.0%
$00.0%$102.25
0
2024-Q4
Increased
1,250
+51.7%
$115,3630.0%$90.02
31
2024-Q3
Increased
824
+421.5%
$109,7400.0%$128.66
35

Other major holders of CURE: CITADEL ADVISORS LLC, SUSQUEHANNA INTERNATIONAL GROUP, LLP

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used